Coumestrol (Coumestan · Most Potent Dietary Phytoestrogen · Bone Density)

Compound	Coumestrol
Chemical class	Polyphenol — Coumestan (Most potent plant phytoestrogen)
CAS	479-13-0
Primary source	Medicago sativa (alfalfa/lucerne), soybean sprouts, clover sprouts
Key applications	Bone density, menopausal support, most potent dietary phytoestrogen
Claim strength	Moderate
Typical form	Alfalfa leaf extract; sprout-derived preparations
Buy from Herbuno	Organic Alfalfa / Lucerne (Medicago sativa) Leaf Powder → Alfalfa Leaf Extract Powder - Medicago sativa →

Name origin: From coumarin (the lactone ring system) + estrol (relating to estrogenic activity) — naming reflects both its chemical structure (benzofuranocoumarin) and its biological activity. Coumestrol is the most potent naturally occurring dietary phytoestrogen, with an ER binding affinity approximately 10–100-fold higher than genistein and daidzein. Traditional use: Alfalfa (Medicago sativa) has traditional use in Ayurveda, Arabic medicine, and North American herbalism for joint health, nutritive support, and as a phytoestrogenic herb. Coumestrol was identified as a key phytoestrogen following investigations into infertility in sheep grazing on coumestrol-rich clover in Australia in the 1940s. Research trajectory: Research covers bone density (ERβ-mediated osteoblast promotion), menopausal symptom management, and reproductive effects. The high estrogenic potency that makes coumestrol pharmacologically interesting also necessitates conservative dosing and advisory language. Commercial source: Coumestrol is commercially available as a minor co-constituent of alfalfa (Medicago sativa) leaf extract and organic alfalfa leaf powder, and as a high-purity isolate from specialist chemical suppliers. See sourcing options below.

---

Evidence for Coumestrol Applications

Bone density and osteogenic activity: Coumestrol is one of the most potent natural ERβ agonists, with documented osteoblast stimulation and osteoclast inhibition in cell and animal models. In ovariectomised rat models, coumestrol at low doses (comparable to dietary exposure levels) preserves bone mineral density as effectively as genistein at higher doses. Small human observational studies correlate alfalfa consumption with bone health markers. Claim strength: Moderate.

Menopausal and reproductive effects: Coumestrol’s high ER affinity gives it potential for menopausal symptom management at very low doses. However, high-potency phytoestrogens carry greater risk of disrupting endogenous hormonal balance. Clinical trials specifically on coumestrol are very limited; evidence derives primarily from alfalfa extract studies. Claim strength: Moderate (mechanism high potency; clinical evidence limited).

Anti-inflammatory and antioxidant: Coumestrol demonstrates antioxidant activity and NF-κB inhibition in cell models, contributing to alfalfa extract’s anti-inflammatory profile. These effects occur at concentrations achievable via dietary/supplement exposure. Claim strength: Moderate.

---

Dosage & Formulator Specification

Coumestrol is not formulated as a standalone isolate at supplement scale. Alfalfa leaf extract delivers coumestrol at approximately 0.01–0.05% of dry extract weight. For a 500 mg/day alfalfa extract dose, coumestrol delivery is approximately 0.05–0.25 mg — very low relative to genistein supplement doses, which reflects coumestrol’s higher intrinsic potency.

Given the very high estrogenic potency relative to other dietary phytoestrogens, formulators should avoid specifying coumestrol at high concentrations in oral supplements. Alfalfa extract at nutritional use levels (0.5–2 g/day) provides physiologically relevant coumestrol exposure consistent with traditional food use contexts.

For skin/topical applications, coumestrol’s estrogenic and antioxidant activity is an area of cosmetic research interest. Standard topical delivery considerations (solubilisation, pH stability) apply. Regulatory classification as a phytoestrogenic ingredient may require additional assessment in some cosmetic markets.

---

Frequently Asked Questions — Coumestrol

How much more estrogenic is coumestrol than genistein?
In competitive ER binding assays, coumestrol shows approximately 10–100-fold higher affinity for ERβ than genistein, and meaningfully higher ERα affinity as well. It is considered the most potent dietary phytoestrogen characterised. This means far lower quantities of coumestrol are needed to achieve equivalent estrogenic exposure to genistein or daidzein, which has both potency and safety implications.

Is the sheep infertility story relevant to human coumestrol exposure?
The Australian sheep infertility cases involved animals grazing continuously on coumestrol-rich subterranean clover (Trifolium subterraneum) at extremely high exposure levels. Human dietary coumestrol exposure from alfalfa sprouts or supplement extracts is orders of magnitude lower. The sheep model identified coumestrol as a potent phytoestrogen; it does not translate directly to human safety concerns at normal consumption levels.

Is coumestrol from alfalfa a concern for hormone-sensitive populations?
At typical alfalfa supplement doses (500 mg–2 g/day extract), coumestrol exposure is very low due to low concentration in the botanical matrix. The same precautionary advisory language as for other phytoestrogenic supplements applies for hormone-sensitive individuals. High-dose isolated coumestrol supplementation would warrant more conservative advisory language, but this is not a current commercial scenario.

Does alfalfa extract standardisation typically include coumestrol?
Not commonly. Alfalfa extracts are typically standardised to saponins, chlorophyll, or total isoflavone content rather than coumestrol specifically. Coumestrol quantification in alfalfa extract requires dedicated HPLC analysis. Request a phytochemical profile including coumestrol if this specific compound is relevant to formulation documentation.

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery